Varenicline for smoking cessation: A placebo-controlled, randomized study
Background and objective: Varenicline tartrate, a novel, selective, nicotinic acetylcholine receptor partial agonist, has been developed specifically as a smoking cessation drug. This study evaluated the efficacy of a standard regimen of varenicline compared with placebo for smoking cessation in 333...
Saved in:
Main Authors: | Chen Wang, Dan Xiao, Kenneth Ping Wah Chan, Chaicharn Pothirat, Dahlia Garza, Simon Davies |
---|---|
Format: | Journal |
Published: |
2018
|
Subjects: | |
Online Access: | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=63849201453&origin=inward http://cmuir.cmu.ac.th/jspui/handle/6653943832/49361 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Chiang Mai University |
Similar Items
-
Varenicline for smoking cessation: A placebo-controlled, randomized study
by: Chen Wang, et al.
Published: (2018) -
Varenicline for smoking cessation: A placebo-controlled, randomized study
by: Wang C., et al.
Published: (2014) -
Clonidine for smoking cessation
by: Arth Nana, et al.
Published: (2018) -
Incentive programmes for smoking cessation: Cluster randomized trial in workplaces in Thailand
by: Justin S. White, et al.
Published: (2020) -
Efficacy and acceptability of varenicline for alcoholism: A systematic review and meta-analysis of randomized-controlled trials
by: Awirut Oon-arom, et al.
Published: (2020)